Related Experiment Videos
Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray
1Department of Pathology and Genetic Pathology Evaluation Center, Department of Pathology, 1st floor JPPN, Vancouver General Hospital, 855 W. 12th Avenue, BC V5Z 1M9, Vancouver, Canada.
Virchows Archiv : an International Journal of Pathology
|March 21, 2003
Summary
This study differentiated cervical and endometrial adenocarcinomas using immunohistochemistry. Certain markers like estrogen receptor (ER) and vimentin help distinguish between these uterine cancers, aiding in accurate diagnosis.
Area of Science:
- Gynecologic Pathology
- Oncology
- Immunohistochemistry
Background:
- Cervical and endometrial adenocarcinomas exhibit overlapping morphology, complicating diagnosis in biopsy specimens.
- Accurate differentiation is crucial for appropriate patient management and treatment strategies.
Purpose of the Study:
- To utilize tissue microarray technology and an extensive antibody panel to define the immunoprofile of cervical and endometrial adenocarcinomas.
- To compare the immunophenotypic differences between primary cervical and endometrial adenocarcinomas.
Main Methods:
- Construction of a tissue microarray from 141 hysterectomy specimens (57 cervical, 84 endometrial adenocarcinomas).
- Immunohistochemical staining of tissue cores with 21 commercially available antibodies.
- Hierarchical clustering analysis to interpret immunostaining results and identify differential expression patterns.
Main Results:
- Estrogen receptor (ER), vimentin, and cytokeratin 8/18 (CK 8/18) were significantly more frequent in endometrial adenocarcinomas.
- Carcinoembryonic antigen (CEA) was expressed more frequently in cervical adenocarcinomas.
- Specific immunoprofiles were identified for endocervical adenocarcinoma (ER(-), vimentin(-), CK 8/18(-), CEA(+)) and endometrial adenocarcinoma (ER(+), vimentin(+), CK 8/18(+), CEA(-)), though many tumors showed intermediate phenotypes.
Conclusions:
- Immunohistochemistry, particularly using ER, vimentin, CK 8/18, and CEA, can aid in distinguishing between cervical and endometrial adenocarcinomas.
- Hierarchical clustering analysis is valuable for interpreting complex immunophenotypes and intermediate cases.
- Papillary serous endometrial adenocarcinoma showed less vimentin expression compared to endometrioid carcinoma.